Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Holding(s) in Company

13 Nov 2013 10:07

RNS Number : 9074S
Croda International PLC
13 November 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Croda International Plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

P

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

P

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

BlackRock, Inc.

4. Full name of shareholder(s)

(if different from 3.): iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

8 November 2013

6. Date on which issuer notified:

12 November 2013

7. Threshold(s) that is/are crossed or

reached: vi, vii

Holding has gone above 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 10p each

 

GB0002335270

 

N/A

N/A

N/A

N/A

6,538,871

N/A

4.82%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

CFD

270,742

Nominal

Delta

 

0.20%

0.20%

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,809,613

5.02%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

BlackRock Investment Management (UK) Limited - 6,809,613 (5.02%)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Number of Croda International Plc ordinary shares in issue, excluding shares held in treasury: 135,781,788

 

14. Contact name:

 Tom Brophy

15. Contact telephone number:

 01405 860551

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBJBMTMBMBBFJ
Date   Source Headline
17th Oct 20179:23 amRNSAppointment of KPMG LLP as External Auditor
11th Oct 20174:59 pmRNSDirector/PDMR Shareholding
4th Oct 20172:36 pmRNSDirector/PDMR Shareholding
14th Sep 20171:50 pmRNSDirector/PDMR Shareholding
12th Sep 20172:17 pmRNSDirector/PDMR Shareholding
11th Aug 20172:20 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSResults for the six months ended 30 June 2017
11th Jul 20174:22 pmRNSDirector/PDMR Shareholding
11th Jul 20173:26 pmRNSDirector/PDMR Shareholding
14th Jun 20172:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20175:45 pmRNSDirector/PDMR Shareholding
22nd May 20173:35 pmRNSHolding(s) in Company
19th May 20174:34 pmRNSHolding(s) in Company
18th May 20174:27 pmRNSHolding(s) in Company
15th May 20176:01 pmRNSHolding(s) in Company
15th May 20175:46 pmRNSDirector/PDMR Shareholding
15th May 20175:31 pmRNSDirector/PDMR Shareholding
15th May 20175:23 pmRNSDirector/PDMR Shareholding
15th May 20175:16 pmRNSDirector/PDMR Shareholding
15th May 20175:13 pmRNSDirector/PDMR Shareholding
15th May 20175:06 pmRNSDirector/PDMR Shareholding
15th May 20175:04 pmRNSDirector/PDMR Shareholding
15th May 20174:56 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
15th May 20171:57 pmRNSTransaction in Own Shares
11th May 20173:01 pmRNSDirector/PDMR Shareholding
27th Apr 201710:09 amRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update for the First Quarter 2017
11th Apr 20173:35 pmRNSDirector/PDMR Shareholding
23rd Mar 20173:27 pmRNSDirector/PDMR Shareholding
20th Mar 20175:45 pmRNSAnnual Financial Report
16th Mar 20173:45 pmRNSDirector/PDMR Shareholding
13th Mar 20172:20 pmRNSDirector/PDMR Shareholding
10th Mar 20174:39 pmRNSDirector/PDMR Shareholding
9th Mar 20174:53 pmRNSDirector/PDMR Shareholding
9th Mar 20179:50 amRNSDirector/PDMR Shareholding
28th Feb 20177:02 amRNSDr Keith Layden to become a Non-Executive Director
28th Feb 20177:00 amRNSResults for the year ended 31 December 2016
14th Feb 201710:37 amRNSDirector/PDMR Shareholding
11th Jan 20174:06 pmRNSDirector/PDMR Shareholding
20th Dec 20165:25 pmRNSDirector/PDMR Shareholding
13th Dec 20165:23 pmRNSDirector/PDMR Shareholding
24th Nov 20162:39 pmRNSHolding(s) in Company
21st Nov 20164:12 pmRNSDirector/PDMR Shareholding
11th Nov 20163:01 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading update for the third quarter of 2016
2nd Nov 20162:59 pmRNSHolding(s) in Company
1st Nov 201611:19 amRNSDirector/PDMR Shareholding
31st Oct 20165:31 pmRNSHolding(s) in Company
31st Oct 20163:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.